Go to the list of all blogs
Anna G's Avatar
published in Blogs
Sep 25, 2023
$HUM, $UNH, $ELV, $CI, $CNC: Managed Healthcare's +2.29% Weekly Rise!

$HUM, $UNH, $ELV, $CI, $CNC: Managed Healthcare's +2.29% Weekly Rise!


Managed Healthcare's Impressive Surge: A Deep Dive into Market Movements and Notable Tickers 🚀

🔍 Theme Description

Managed healthcare firms, including giants like $HUM, $UNH, and $ELV, are in the limelight, registering a +2.29% gain in just a week! Here’s an analysis of what’s propelling these stocks.


🏥📈 Uncover Opportunities in Managed Healthcare with AI! 💼💉

The world of managed healthcare offers intriguing prospects, and our AI-powered trading tools are your companions for success in this sector.

📉 "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" equips you with the skills to navigate markets trending down, potentially unlocking gains even in challenging conditions.

📈 If you're looking to capitalize on upward trends, "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" is designed to identify these opportunities, empowering you to make informed trading decisions.

With AI precision by your side, you can confidently explore the managed healthcare sector, identify trends, and make strategic moves. Stay ahead of the curve, manage risk, and potentially enhance your returns. Your journey to trading success starts here! 🚀📊

Discover the future of trading with AI expertise! 💰🤖

 

Tickers of this Group:

$CI $HUM $UNH $MOH $CNC $BIOS $ELV

💼 Industry Overview

Managed healthcare encompasses giants like Humana Inc., Unitedhealth Group Inc., and Molina Healthcare Inc., which specialize in health insurance and related services. Their chief aim? Cutting healthcare costs for consumers. With a solid growth trajectory, these stocks are setting the stage for future advancements.

💰 Market Cap

Diving into the financials, the average market cap for our theme is a whopping 111.1B. Leading the pack, $UNH boasts a 468.8B valuation, with $BIOS trailing at a still respectable 209.4M.

📈 High and Low Price Notable News

In recent times, the average weekly growth rate is 2.29%. Specifically, $HUM shines with a 4.95% spike, while $BIOS lags behind, dropping by 0.28%. Noteworthy shifts include $CI, which declined -6.36% and $CNC, dipping by -5.56%.

🎛 Volume Insights

Volume patterns reveal a -21.38% weekly average, a -42.95% monthly dip but a quarterly upswing of 97.81%. Stocks making waves? $HUM with a daily growth of 150% and Molina Healthcare, with a 355% spike!

🔢 Fundamental Analysis Ratings

A quick snapshot:

  • Valuation Rating: 49
  • P/E Growth Rating: 66
  • Price Growth Rating: 43
  • SMR Rating: 73
  • Profit Risk Rating: 37
  • Seasonality Score: 42

📊 Ticker Deep Dive

  • $CI: A bullish sign emerges as the 10-day MA goes beyond the 50-day average. Over the next month, there's an 86% chance this uptrend will continue.

  • $HUM: Yet another strong player, Humana's price surpassed its 50-day MA on September 05, 2023. History suggests a 73% probability of this uptrend lasting.

  • $UNH: Unitedhealth Group witnesses a crossover - its 50-day MA surpasses the 200-day MA. This long-term bullish indicator shows a trend shift upwards.

  • $ELV: On August 31, 2023, ELV broke its lower Bollinger Band, hinting at a potential rise. Historically, in 73% of similar scenarios, prices ascended the following month.

✨ The managed healthcare sector, with its positive outlook and strong fundamentals, is carving out a space in the limelight. Whether you're observing $HUM's uptrend or $UNH's massive market cap, the sector is ripe with opportunities for discerning traders. Keep a close watch! 📈🔥

 

Related Ticker: CI, HUM, UNH, MOH, CNC, BIOS, ELV

CI in downward trend: price may decline as a result of having broken its higher Bollinger Band on September 14, 2026

CI broke above its upper Bollinger Band on September 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 44 similar instances where the stock broke above the upper band. In 30 of the 44 cases the stock fell afterwards. This puts the odds of success at 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CI as a result. In 50 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 54%.

The Moving Average Convergence Divergence Histogram (MACD) for CI turned negative on September 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 30 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 58%.

CI moved below its 50-day moving average on September 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CI crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 44%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +1.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where CI advanced for three days, in 226 of 356 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 170 of 274 cases where CI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.707) is normal, around the industry mean (3.378). P/E Ratio (11.385) is within average values for comparable stocks, (147.588). Projected Growth (PEG Ratio) (0.749) is also within normal values, averaging (0.803). CI has a moderately high Dividend Yield (0.023) as compared to the industry average of (0.009). P/S Ratio (0.264) is also within normal values, averaging (0.569).

The Tickeron Seasonality Score of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating fairly steady price growth. CI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 56 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), CVS HEALTH Corp (NYSE:CVS), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 65.36B. The market cap for tickers in the group ranges from 335.99K to 338.3B. UNH holds the highest valuation in this group at 338.3B. The lowest valued company is IHGP at 335.99K.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was -6%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 60%. UNH experienced the highest price growth at 0%, while ALHC experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was 149%. For the same stocks of the Industry, the average monthly volume growth was 205% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 38
P/E Growth Rating: 45
Price Growth Rating: 42
SMR Rating: 72
Profit Risk Rating: 87
Seasonality Score: 8 (-100 ... +100)
View a ticker or compare two or three
CI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of health insurance services

Industry ManagedHealthCare

Profile
Details
Industry
Managed Health Care
Address
900 Cottage Grove Road
Phone
+1 860 226-6000
Employees
67700
Web
https://www.thecignagroup.com
Interact to see
Advertisement
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.